FindTrial
Sign In

The efficacy and safety of improved Mohs' paste for gynecological malignancy: multicenter prospective trial

The efficacy and safety of improved Mohs' paste for gynecological malignancy: multicenter prospective trial - The efficacy and safety of Mohs' paste for gynecological malignancy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031287
Enrollment
30
Registered
2018-02-14
Start date
2017-11-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecological malignancy(including metastatic)

Interventions

Morhs&#39
paste + 10% Zinc oxide single ointment

Sponsors

Kagoshima University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) Observance of clinical symptoms due to gynecological malignancy 2) Resistant to anti-cancer agents or difficult to treat 3) Patient consent has been obtained from the patient in writing

Exclusion criteria

Exclusion criteria: 1) Pregnant patients, possibility of pregnancy, postpartum within 28 days, lactating 2) Patients judged by doctor to be unsuitable for study

Design outcomes

Primary

MeasureTime frame
Technique completion, condition control(hemostasis, foul smell, discharge)—

Secondary

MeasureTime frame
Survival, pain level, other complication—

Countries

Japan

Contacts

Public ContactShintaro Yanazume

Kagoshima University Hospital Obstetrics & Gynecoogy

s-yana@m3.kufm.kagoshima-u.ac.jp099-275-5423

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026